Literature DB >> 21143480

The effect of dialysis chains on mortality among patients receiving hemodialysis.

Yi Zhang1, Dennis J Cotter, Mae Thamer.   

Abstract

OBJECTIVE: To examine the association between dialysis facility chain affiliation and patient mortality. STUDY
SETTING: Medicare dialysis population. STUDY
DESIGN: Data from the United States Renal Data System (USRDS) were used to identify 3,601 free-standing dialysis facilities and 34,914 Medicare patients' incidence to end-stage renal disease (ESRD) in 2004. Mixed-effect regression models were used to estimate patient mortality by dialysis facility chain and profit status during the 2-year follow-up. DATA COLLECTION: USRDS data were matched with facility, cost, and census data. PRINCIPAL
FINDINGS: Of the five largest dialysis chains, the lowest mortality risk was observed among patients dialyzed at nonprofit (NP) Chain 5 facilities. Compared with Chain 5, hazard ratios were 19 percent higher (95 percent CI 1.06-1.34) and 24 percent higher (95 percent CI 1.10-1.40) for patients dialyzed at for-profit (FP) Chain 1 and Chain 2 facilities, respectively. In addition, patients at FP facilities had a 13 percent higher risk of mortality than those in NP facilities (95 percent CI 1.06-1.22).
CONCLUSIONS: Large chain affiliation is an independent risk factor for ESRD mortality in the United States. Given the movement toward further consolidation of large FP chains, reasons behind the increase in mortality require scrutiny. © Health Research and Educational Trust.

Entities:  

Mesh:

Year:  2010        PMID: 21143480      PMCID: PMC3097400          DOI: 10.1111/j.1475-6773.2010.01219.x

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  43 in total

Review 1.  Income inequality and mortality: importance to health of individual income, psychosocial environment, or material conditions.

Authors:  J W Lynch; G D Smith; G A Kaplan; J S House
Journal:  BMJ       Date:  2000-04-29

Review 2.  Multilevel analysis in public health research.

Authors:  A V Diez-Roux
Journal:  Annu Rev Public Health       Date:  2000       Impact factor: 21.981

3.  A national study of efficiency for dialysis centers: an examination of market competition and facility characteristics for production of multiple dialysis outputs.

Authors:  Hacer Ozgen; Yasar A Ozcan
Journal:  Health Serv Res       Date:  2002-06       Impact factor: 3.402

4.  Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD.

Authors:  J Craig Longenecker; Josef Coresh; Michael J Klag; Andrew S Levey; Alice A Martin; Nancy E Fink; Neil R Powe
Journal:  J Am Soc Nephrol       Date:  2000-03       Impact factor: 10.121

5.  Medicare program: Medicare Advantage and prescription drug programs MIPPA drug formulary & protected classes policies. Interim final rule with comment period.

Authors: 
Journal:  Fed Regist       Date:  2009-01-16

6.  Opinions regarding outcome differences in European and US haemodialysis patients.

Authors:  C Ronco; D Marcelli
Journal:  Nephrol Dial Transplant       Date:  1999-11       Impact factor: 5.992

7.  Multilevel modeling in epidemiology with GLIMMIX.

Authors:  J S Witte; S Greenland; L L Kim; L Arab
Journal:  Epidemiology       Date:  2000-11       Impact factor: 4.822

8.  Income-based disparities in outcomes for patients with chronic kidney disease.

Authors:  P P Garg; M Diener-West; N R Powe
Journal:  Semin Nephrol       Date:  2001-07       Impact factor: 5.299

9.  Quality of care differences by ownership in United States renal dialysis facilities.

Authors:  R A Irvin
Journal:  ASAIO J       Date:  2000 Nov-Dec       Impact factor: 2.872

10.  How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices.

Authors:  Jeannette G van Manen; Johanna C Korevaar; Friedo W Dekker; Elisabeth W Boeschoten; Patrick M M Bossuyt; Raymond T Krediet
Journal:  Am J Kidney Dis       Date:  2002-07       Impact factor: 8.860

View more
  16 in total

1.  Do health outcomes vary by profit status of hemodialysis units?

Authors:  Barry M Straube
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-26       Impact factor: 8.237

2.  Geographic variation and neighborhood factors are associated with low rates of pre-end-stage renal disease nephrology care.

Authors:  Hua Hao; Brendan P Lovasik; Stephen O Pastan; Howard H Chang; Ritam Chowdhury; Rachel E Patzer
Journal:  Kidney Int       Date:  2015-04-22       Impact factor: 10.612

3.  For-profit status and industry evolution in health care markets: evidence from the dialysis industry.

Authors:  Nathan E Wilson
Journal:  Int J Health Econ Manag       Date:  2016-07-14

4.  Organizational status of dialysis facilities and patient outcome: does higher injectable medication use mediate increased mortality?

Authors:  Yi Zhang; Mae Thamer; Onkar Kshirsagar; Dennis J Cotter
Journal:  Health Serv Res       Date:  2012-12-06       Impact factor: 3.402

5.  Patient care staffing levels and facility characteristics in U.S. hemodialysis facilities.

Authors:  Laura A G Yoder; Wenjun Xin; Keith C Norris; Guofen Yan
Journal:  Am J Kidney Dis       Date:  2013-06-28       Impact factor: 8.860

6.  Variation in dialysis quality measures by facility, neighborhood, and region.

Authors:  Milda R Saunders; Marshall H Chin
Journal:  Med Care       Date:  2013-05       Impact factor: 2.983

7.  Conflicts of interest in dialysis: A barrier to policy reforms.

Authors:  Aaron Glickman; Eugene Lin; Jeffrey S Berns
Journal:  Semin Dial       Date:  2020-01-03       Impact factor: 3.455

8.  Comparison of hospitalization rates among for-profit and nonprofit dialysis facilities.

Authors:  Lorien S Dalrymple; Kirsten L Johansen; Patrick S Romano; Glenn M Chertow; Yi Mu; Julie H Ishida; Barbara Grimes; George A Kaysen; Danh V Nguyen
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-26       Impact factor: 8.237

9.  Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System.

Authors:  Brian M Brady; Bo Zhao; Jingbo Niu; Wolfgang C Winkelmayer; Arnold Milstein; Glenn M Chertow; Kevin F Erickson
Journal:  JAMA Intern Med       Date:  2018-10-01       Impact factor: 21.873

10.  Facility size, race and ethnicity, and mortality for in-center hemodialysis.

Authors:  Guofen Yan; Keith C Norris; Wenjun Xin; Jennie Z Ma; Alison J Yu; Tom Greene; Wei Yu; Alfred K Cheung
Journal:  J Am Soc Nephrol       Date:  2013-08-22       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.